Overview

Enoxaparin Versus Unfractionated Heparin in PCI

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
Enoxaparin 0.75mg/kg BW is not inferior to weight adjusted unfractionated heparin as anticoagulation for PCI
Phase:
Phase 4
Details
Lead Sponsor:
Triemli Hospital
Treatments:
Calcium heparin
Enoxaparin
Heparin